Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus

被引:0
|
作者
Ibrahim, HA
El-Meligi, AA
Abdel-Hamid, M
Elhendy, A [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA
[2] Cairo Univ Hosp, Dept Internal Med, Cairo, Egypt
[3] Cairo Univ Hosp, Dept Cardiol, Cairo, Egypt
来源
MEDICAL SCIENCE MONITOR | 2004年 / 10卷 / 03期
关键词
diabetes mellitus; oxidative stress; microalbuminurea; von Willebrand factor; coronary artery disease;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: To assess the relations among plasma levels of von Willebrand factor (vWf), microalbuminuria and markers of oxidative stress in patients with type 2 diabetes mellitus. Material/Methods: We studied 10 healthy subjects without microalbuminuria or history of coronary artery disease (CAD) and 30 patients with type 2 diabetes mellitus who were classified into three groups, each including 10 patients of matched age and sex; group 1: patients without microalbuminuria or history of CAD; group 2: patients with microalbuminuria and no history of CAD, and group 3: patients with microalbuminuria and history of CAD. All subjects underwent laboratory measurements of vWf, albumin excretion rate (AER), malondialdehyde, vitamin C, reduced glutathione and C peptide. Results: vWf was elevated in patients with type 2 diabetes mellitus compared with control subjects. However, levels were higher in patients with than without microalbuminuria and in patients with than without a history of CAD (96 +/- 12, 124 +/- 7, 149 +/- 9, 175 +/- 7 in the control subjects and the diabetic patients' groups respectively). There was a positive correlation between vWf and AER, MDA and C- peptide (r = 0.91, 0.98, 0.96, p < 0.0001) and a negative correlation between vWf and both vitamin C and reduced glutathione (r = -0.59 and -0.62 respectively, p < 0.001). Conclusions: vWf levels are elevated in patients with type 2 diabetes mellitus, particularly in the presence of microalbuminuria and history of CAD. vWf levels are associated with markers of increased oxidative stress and therefore reflect the severity of biochemical abnormalities, which contribute to diabetic vascular disease.
引用
收藏
页码:CR85 / CR89
页数:5
相关论文
共 50 条
  • [41] Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus
    Ichiro Wakabayashi
    Hiroshi Masuda
    Journal of Thrombosis and Thrombolysis, 2009, 27 : 29 - 35
  • [42] Effect of microalbuminuria on macular thickness in patients with type-2 diabetes mellitus
    Atilgan, Cemile Ucgul
    Atilgan, Kadir Gokhan
    Kosekahya, Pinar
    Caglayan, Mehtap
    Sendul, Selam Yekta
    Yilmazbas, Pelin
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (01) : 19 - 25
  • [43] Effect of nebivolol on microalbuminuria in hypertensive patients with or without type 2 diabetes mellitus
    Merugu, Padma Latha
    Bingi, Thrilok Chander
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2020, 11 (01) : 13 - 18
  • [44] Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study
    Hisashi Makino
    Miki Matsuo
    Ai Hishida
    Ryo Koezuka
    Mayu Tochiya
    Yoko Ohata
    Tamiko Tamanaha
    Cheol Son
    Yoshihiro Miyamoto
    Kiminori Hosoda
    Diabetology International, 2019, 10 : 148 - 152
  • [45] Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus
    Wakabayashi, Ichiro
    Masuda, Hiroshi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 27 (01) : 29 - 35
  • [46] Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study
    Makino, Hisashi
    Matsuo, Miki
    Hishida, Ai
    Koezuka, Ryo
    Tochiya, Mayu
    Ohata, Yoko
    Tamanaha, Tamiko
    Son, Cheol
    Miyamoto, Yoshihiro
    Hosoda, Kiminori
    DIABETOLOGY INTERNATIONAL, 2019, 10 (02) : 148 - 152
  • [47] Association between oxidative-stress-related markers and calcified femoral artery in type 2 diabetes patients
    Andujar-Vera, Francisco
    Garcia-Fontana, Cristina
    Lozano-Alonso, Silvia
    Gonzalez-Salvatierra, Sheila
    Iglesias-Baena, Ivan
    Munoz-Torres, Manuel
    Garcia-Fontana, Beatriz
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 190
  • [48] Oxidative Stress in Type II Diabetes Mellitus
    Bikkad, Mahendra D.
    Somwanshi, Sachin D.
    Ghuge, Sandeep H.
    Nagane, N. S.
    BIOMEDICAL RESEARCH-INDIA, 2014, 25 (01): : 84 - 87
  • [49] Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease
    Sztukowska, M.
    Gallinaro, L.
    Cattini, M. G.
    Pontara, E.
    Sartorello, F.
    Daidone, V.
    Padrini, R.
    Pagnan, A.
    Casonato, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (01) : 107 - 114
  • [50] PLASMA TOTAL HOMOCYSTEINE, LIPOPROTEIN (A) AND VON WILLEBRAND FACTOR LEVELS IN ASSESSMENT OF METABOLIC CONTROLS OF CHILDREN WITH TYPE I DIABETES MELLITUS
    Ertugrul, Sabahattin
    Sen, Yasar
    Yilmaz, Erdal
    Aydin, Mustafa
    Ustundag, Bilal
    NOBEL MEDICUS, 2014, 10 (03): : 75 - 80